Press releases

5
Aug 2020
20:30 E.S.T.

Cellectis Provides Business Update and Reports Financial Results for Second Quarter and First Six Months 2020

Read more
29
Jul 2020
20:30 E.S.T.

Cellectis to Hold Second Quarter 2020 Earnings Call on Thursday, August 6, 2020 at 7:30AM EDT

Read more
21
Jul 2020
20:30 E.S.T.

Cellectis Appoints Biopharma Veteran Steve Doares, Ph.D., as Senior Vice President of US Manufacturing

Read more
6
Jul 2020
21:20 E.S.T.

To Fully Focus on Cellectis, Dr. André Choulika Retires From Calyxt’s Board of Directors

Read more
6
Jul 2020
20:50 E.S.T.

Cellectis Reports Clinical Hold Placed on MELANI-01 Study

Read more
29
Jun 2020
20:30 E.S.T.

Cellectis S.A. Reports Results from Annual Shareholders’ General Meeting Held on June 29, 2020

Read more
25
Jun 2020
20:30 E.S.T.

Cellectis Published Streamlined Manufacturing Method to Generate Ultrapure Allogeneic CAR T-Cell Therapies

Read more
18
May 2020
20:30 E.S.T.

Cellectis Appoints Biopharma Veteran Leopold Bertea as Senior Vice President of Technical Operations – Europe

Read more
11
May 2020
20:30 E.S.T.

Cellectis’ Annual Shareholders’ General Meeting to be Held on June 29, 2020

Read more
6
May 2020
20:30 E.S.T.

Cellectis Provides Business Update and Reports Financial Results for First Quarter 2020

Read more

Press contacts

For more information on any story, or for press enquiries, get in touch with our communication team

CONTACT US